Medinotec (MDNC) Revenue Growth (1y) (2023 - 2026)
Medinotec (MDNC) Revenue Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn | 16.70% |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn | 7.41% |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 15.05% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 6.08% |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 24.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 24.23% |
| Feb 28, 2026 | -48.31% |
| Nov 30, 2025 | -1.09% |
| Aug 31, 2025 | 79.39% |
| May 31, 2025 | 70.47% |
| Feb 28, 2025 | 56.62% |
| Nov 30, 2024 | 28.09% |
| Aug 31, 2024 | 414.27% |
| May 31, 2024 | 200.78% |
| Feb 29, 2024 | 706.06% |
| Nov 30, 2023 | 416.13% |
| Aug 31, 2023 | 158.16% |
| May 31, 2023 | 111.84% |
| Feb 28, 2023 | -52.67% |